A trial of targeted drugs for bile duct cancer and gallbladder cancer (SAFIR-ABC10)
This trial is looking at targeted drugs for bile duct cancer and gallbladder cancer that has spread to another part of the body or has come back after treatment
This trial is looking at targeted drugs for bile duct cancer and gallbladder cancer that has spread to another part of the body or has come back after treatment
This trial is comparing stereotactic body radiotherapy to the prostate with stereotactic body radiotherapy to the prostate and lymph nodes in the pelvis.
This trial is comparing fluorescence guided surgery to standard surgery for people with sarcoma.
This study is looking at gene changes in advanced solid cancers. This might help your team find a suitable early trial of a new targeted treatment for you.
This trial is looking at adding oleclumab or monalizumab to durvalumab for non small cell lung cancer.
This trial is looking at a drug called polatuzumab vedotin in combination with a treatment called RICE for B cell lymphoma.
This trial is looking at zanubrutinib for primary central nervous system lymphoma.
This trial is looking at matching targeted treatment to people who have a rare cancer.
This trial is looking at adding certain targeted drugs to radiotherapy for head and neck cancer.